The following media kits are made available to provide reporters with background information on the range of Medtronic diabetes therapies and the conditions they treat.
Information about the MiniMed™ 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.
Information about the InPen™ smart insulin pen system.
Information about the MiniMed™ 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.
Information about the Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.^
Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.
* Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
^ Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.